Back to Search
Nylia 7/7/7
by Aurobindo Pharma LimitedContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.035Mg,0.035Mg,0.035Mg

Progestin

Norethindrone

0.5Mg,0.75Mg,1Mg

Regimen Protocol

Triphasic 28 day

Androgenicity

Moderate

Approval Date

10/21/2016

Additives
None
Inactive Ingredients
anhydrous lactoselactose monohydratepregelatinized starch (maize)magnesium stearateFD&C Yellow #6 aluminum lakecroscarmellose sodiumFD&C Blue No. 2 aluminum lakeferric oxide yellowmicrocrystalline cellulosepovidone

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Glenmark Pharmaceuticals Ltd

Alyacen 7/7/7

Northstar Rx LLC

Dasetta 7/7/7

Barr Laboratories Inc

Nortrel 7/7/7
Nortrel 7/7/7

Have clinical questions about Nylia 7/7/7?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy